The Zambia AIDS Related Tuberculosis (ZAMBART) Project is a Zambian NGO formed in 2004 from a collaboration between the University of Zambia’s School of Medicine and the London School of Hygiene and Tropical Medicine that spans more than 20 years. From the initial studies of the impact of HIV on the clinical presentation and outcome of tuberculosis, the scope and partnership of the research have expanded widely.
Based in Lusaka, ZAMBART now collaborates closely with government, non-governmental and academic institutions within Zambia, Africa and the rest of the world. ZAMBART staff form an interdisciplinary team with a range of expertise including epidemiology, clinical science, social science, laboratory, operations research, health systems and services research, health policy analysis, health economics, development communication and counselling.
ZAMBART focuses on the overlap between HIV and TB in order to improve the quality of life of people affected by the dual epidemic. Conducting research within a limited resource setting, ZAMBART is committed to:
Bridging research and action through operational research and through forging effective collaboration with local stakeholders;
Providing evidence-based and high quality research;
Addressing relevant and priority questions;
Capacity building for Zambian research – scientific and managerial
Areas Of Operation
ZAMBART research is taking place in Lusaka (Chawama, Kanyama, George and Chipata), Kabwe (Makululu and Ngungu), Choma (Shampande and Pemba/Batoka), Livingstone (Dambwa and Maramba), Ndola (Chifubu and Chipulukusu), Kitwe (Chimwemwe and Ndeke), Mansa (Senama and Mansa Central) and Chipata (Eastern Province).
Internationally, ZAMBART is recognised as one of the foremost TB/HIV research groups in the world. Representatives sit on WHO TB/HIV working group and have assisted in the writing of WHO technical guidelines and policy documents. In addition, ZAMBART is actively involved in regional and international research consortia through TARGETS, Evidence for Action and the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE).